Wednesday, Oct 4, 2023
We are thrilled to announced that Oxomics has been awarded £1.25m in Innovate UK Biomedical Catalyst grant funding to accelerate the development of our AI and metabolite-based cancer detection technology.
Read moreThursday, Jan 6, 2022
A selection of Oxomics appearances in local, national and international media.
Read moreWednesday, Jan 5, 2022
Today we published our study in Clinical Cancer Research outlining how our new blood test can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.
Read moreThursday, Dec 9, 2021
Oxomics are very pleased to announce that they’ve been selected as the overall winner of the 2021 Oxford AHSN Accelerator, receiving £50,000 worth of business support from WAPG.
Read moreThursday, Mar 18, 2021
Oxomics were yesterday awarded a pitch award at the UK BioIndustry Association PULSE programme for up and coming life science entrepreneurs.
Read more